Abstract
Over the years, polo-like kinase 1 (PLK1) has garnered great interest as a therapeutic target. The PLK1 is a member of a highly conserved serine/threonine kinase family that plays pivotal roles in mitosis, cytokinesis and DNA damage response in eukaryotic cells. In this review, we summarize the functions of PLK1 during cell cycle progression, its roles in human pediatric cancer and its value as a prognostic factor. Furthermore, we introduce the advances in pharmacological inhibition and the newly chemotherapeutic development of small-molecules to target PLK1 in cancer treatment. Finally, clinical trials with PLK1 inhibitors are briefly reviewed.
Keywords: Chemotherapy, inhibitors, pediatric tumors, PLK1, radiotherapy, treatment.
Current Drug Targets
Title:PLK1 Inhibition: Prospective Role for the Treatment of Pediatric Tumors
Volume: 17 Issue: 14
Author(s): Julia Alejandra Pezuk, Elvis Terci Valera and María Sol Brassesco
Affiliation:
Keywords: Chemotherapy, inhibitors, pediatric tumors, PLK1, radiotherapy, treatment.
Abstract: Over the years, polo-like kinase 1 (PLK1) has garnered great interest as a therapeutic target. The PLK1 is a member of a highly conserved serine/threonine kinase family that plays pivotal roles in mitosis, cytokinesis and DNA damage response in eukaryotic cells. In this review, we summarize the functions of PLK1 during cell cycle progression, its roles in human pediatric cancer and its value as a prognostic factor. Furthermore, we introduce the advances in pharmacological inhibition and the newly chemotherapeutic development of small-molecules to target PLK1 in cancer treatment. Finally, clinical trials with PLK1 inhibitors are briefly reviewed.
Export Options
About this article
Cite this article as:
Pezuk Alejandra Julia, Valera Terci Elvis and Brassesco Sol María, PLK1 Inhibition: Prospective Role for the Treatment of Pediatric Tumors, Current Drug Targets 2016; 17 (14) . https://dx.doi.org/10.2174/1389450116666150825120235
DOI https://dx.doi.org/10.2174/1389450116666150825120235 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Natural Compounds as Anticancer Agents Targeting DNA Topoisomerases
Current Genomics The Use of Radioactive Iodine in the Management of Hyperthyroidism in Children
Current Drug Targets - Immune, Endocrine & Metabolic Disorders AT Islands - Their Nature and Potential for Anticancer Strategies
Current Cancer Drug Targets Hepatoma Derived Growth Factor is a Nuclear Targeted Mitogen
Current Drug Targets Beta-Adrenoreceptor Modulation of Metabolic, Endocrine and Immunologic Function During Critical Illness
Endocrine, Metabolic & Immune Disorders - Drug Targets Glycomics: Relevance for Personalized Medicine
Current Pharmacogenomics and Personalized Medicine The Chemistry and Bio-Medicinal Significance of Pyrimidines & Condensed Pyrimidines
Current Topics in Medicinal Chemistry Drug Discoveries Towards Kv1.5 Potassium Channel
Current Topics in Medicinal Chemistry PET Radioligands for In Vivo Visualization of Neuroinflammation
Current Pharmaceutical Design Anticancer Agents for Treatment of Tumors in the Central Nervous System by Correspondent Substituent Substitution and Elucidation by Pattern Recognition Methods
Medicinal Chemistry Improvement of Model for Prediction of Hemagglutinin Mutations in H5N1 Influenza Viruses with Distinguishing of Arginine, Leucine and Serine
Protein & Peptide Letters Drug Repurposing Strategy against Fungal Biofilms
Current Topics in Medicinal Chemistry Knowledge, Attitude, and Behavior in Avoiding Environmental Tobacco Smoke Exposure at Home among Pregnant Women
Current Women`s Health Reviews Exploring Modifications in Fetal Telomere Programming in Mothers Exposed to Multiple Risk Factors
Current Women`s Health Reviews Nosocomial Tracheobronchitis and Pneumonia Continuum - Target for Inhaled Antibiotics?
Current Respiratory Medicine Reviews Persistent GP130/STAT3 Signaling Contributes to the Resistance of Doxorubicin, Cisplatin, and MEK Inhibitor in Human Rhabdomyosarcoma Cells
Current Cancer Drug Targets Vasopressin and Related Peptides; Potential Value in Diagnosis, Prognosis and Treatment of Clinical Disorders
Current Drug Metabolism Technological Prospecting: Mapping Patents on L-asparaginases from Extremophilic Microorganisms
Recent Patents on Biotechnology DNA Methylation: An Epigenetic Insight into Type 2 Diabetes Mellitus
Current Pharmaceutical Design The Crosstalk between Gut Microbiota, Intestinal Immunological Niche and Visceral Adipose Tissue as a New Model for the Pathogenesis of Metabolic and Inflammatory Diseases: The Paradigm of Type 2 Diabetes Mellitus
Current Medicinal Chemistry